Table 2.
Molecular characteristics of the 22 tigecycline non-susceptible K. pneumoniae isolates with ceftriaxone or ceftazidime (MIC >1 mg/L)
Isolate | Tigecycline MIC | Ertapenem MIC | TEM | SHV | CTX-M | DHA-1 |
---|---|---|---|---|---|---|
1 |
3 |
<0.5 |
— |
SHV-1 |
— |
+ |
2 |
3 |
<0.5 |
— |
SHV-12 |
— |
+ |
3 |
3 |
8 |
— |
-a |
— |
— |
4 |
3 |
<0.5 |
TEM-1 |
SHV-11 |
— |
— |
5 |
4 |
<0.5 |
TEM-1 |
SHV-11 |
CTXM-15 |
+ |
6 |
4 |
2 |
— |
SHV-1 |
CTXM-15 |
+ |
7 |
4 |
<0.5 |
— |
SHV-12 |
— |
+ |
8 |
4 |
<0.5 |
— |
SHV-31 |
— |
+ |
9 |
4 |
<0.5 |
TEM-1 |
SHV-2 |
— |
— |
10 |
4 |
1 |
TEM-1 |
SHV-1 |
CTXM-15 |
+ |
11 |
6 |
8 |
— |
SHV-2 |
— |
+ |
12 |
6 |
4 |
— |
SHV-1 |
— |
+ |
13 |
6 |
<0.5 |
TEM-1 |
SHV-1 |
CTXM-15 |
+ |
14 |
6 |
<0.5 |
TEM-1 |
SHV-1 |
CTXM-15 |
+ |
15 |
6 |
<0.5 |
TEM-1 |
SHV-11 |
— |
+ |
16 |
6 |
1 |
TEM-1 |
SHV-11 |
— |
+ |
17 |
8 |
1 |
TEM-1 |
SHV-11 |
CTXM-14 |
+ |
18 |
8 |
<0.5 |
— |
SHV-12 |
— |
+ |
19 |
8 |
<0.5 |
— |
—a |
— |
+ |
20 |
8 |
8 |
— |
SHV-31 |
— |
— |
21 |
16 |
<0.5 |
— |
SHV-11 |
— |
+ |
22 | 32 | <0.5 | TEM-1 | SHV-11 | — | + |
aThe result showed OPK-B.